Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity

Nakov Radislav V.; Nakov Ventsislav N.; Gerova Vanya A.; Tankova Lyudmila T.

doi:10.2478/folmed-2018-0071

Folia Medica (Jun 2019)

Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity

Nakov Radislav V.,
Nakov Ventsislav N.,
Gerova Vanya A.,
Tankova Lyudmila T.

Affiliations

Nakov Radislav V.: Clinic of Gastroenterology, Queen Giovanna University Hospital, Medical University, Sofia, Bulgaria
Nakov Ventsislav N.: Clinic of Gastroenterology, Queen Giovanna University Hospital, Medical University, Sofia, Bulgaria
Gerova Vanya A.: Clinic of Gastroenterology, Queen Giovanna University Hospital, Medical University, Sofia, Bulgaria
Tankova Lyudmila T.: Clinic of Gastroenterology, Queen Giovanna University Hospital, Medical University, Sofia, Bulgaria

DOI: https://doi.org/10.2478/folmed-2018-0071
Journal volume & issue: Vol. 61, no. 2
pp. 188 – 196

Abstract

Read online

Background: It is essential in clinical management to determine the disease activity in ulcerative colitis (UC) patients. At present, the most accurate way of evaluating the UC severity is endoscopy with biopsy. Fecal calprotectin (FCP) is a non-invasive biomarker that is frequently used for monitoring of intestinal inflammation.

Published in Folia Medica

ISSN: 0204-8043 (Print); 1314-2143 (Online)
Publisher: Pensoft Publishers
Country of publisher: Bulgaria
LCC subjects: Medicine
Website: https://foliamedica.bg

About the journal

Abstract

Keywords